Editorial: The stumble toward virtual careVirtual care is here to stay but now we need to iron out the kinks. Scribble and doodle—for serious clinicians Q and A: Maple-ing virtual solutions Maple CEO Dr. Brett Belchetz takes on criticism of his service and makes an argument for the future of virtual care fee codes. Adverse effect rates with Pfizer-BioNTech and Moderna COVID-19 vaccines Active surveillance system collects near–real-time data from mRNA COVID-19 vaccine recipients in the United States. Costing virtual care Picking out what virtual care fee codes will do to physician services budgets is hard with COVID changing all aspects of utilization. Getting up to speed with new asthma guidelines Tips to help with adherence. Are we replaceable? AI-assisted surgeries are already happening. Algorithms are counselling people. Should we be getting ready for our replacement? Virtual solutions Some provincial governments haven’t committed to continuing virtual care fee codes after the pandemic. Book review: Posner puts Pharma under the microscope A book neither pharma-sympathetic, nor anti-pharma, it still offers up big insights on the pharmaceutical industry. Solve my problem: What methods does your practice use to track and encourage appropriate vaccinations? First Previous 459 460 461 462 463 Next Last
